15 May 2017

EarlySense Teams Up with Lachesis on New Intelligent Ward Patient Monitoring Solution for Chinese Market

Customize font size:

Ramat Gan, Israel, May, 15, 2017 –  EarlySense, the market leader in contact-free continuous monitoring solutions, announced today that Shenzhen Lachesis Mhealth, China’s leading intelligent healthcare developer and sister company of leading medical corporation United Imaging Healthcare (UIH), has integrated EarlySense’s InSight™ contactless monitoring technology into its new Intelligent Hospital Ward Solution. The joint platform, designed for general ward staff and patients, will be unveiled at the China International Medical Equipment Fair (CMEF Spring 2017), taking place May 15 – 18 at the National Exhibition and Convention Center in Shanghai (booth #H2-D03).

Lachesis’ Intelligent Hospital Ward Solution provides a complete suite of technologies that enable an advanced and streamlined healthcare flow to deliver more efficient and improved medical services. The platform includes a closed-loop infusion management system, intelligent diagnosis and treatment assistant, nurse digital assistant device, nurse information system, IoT management and a variety of patient monitoring sensors. With the addition of EarlySense, real-time cardiac and respiratory data and notifications will be relayed to the nurses’ station, as well as handheld devices and other remote viewing displays within the facility.

“The need to continuously monitor post-acute care patients is growing, and we are pleased to collaborate with leading smart sensor developer EarlySense on a solution that will prove essential to both patients and healthcare staff across the region,” said Shuangquan Zhu, CEO of Shenzhen Lachesis Mhealth. “Our platform combines wireless sensing technology and advanced analytics to create a seamless, end-to-end solution for safe, cost-effective monitoring of general care patients.”

Placed under a bed mattress, EarlySense’s patented sensor accurately and continuously monitors patient heart rate, respiratory rate and movement without ever touching the patient. Leveraging advanced algorithms that analyze two patient data points per second, the solution assists healthcare teams with early detection of patient deterioration, helping to prevent adverse events, including code blues, patient falls and pressure ulcers.

“We are pleased to collaborate with Lachesis to bring our clinically-proven sensors to China, to help improve patient care and empower health teams,” said Yfat Scialom, VP of International Sales and Marketing of EarlySense. “China is a key market in our global strategy and we look forward to working together to provide best-in-class solutions to one of the world’s largest markets, and to positively impacting healthcare in the region.”